Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD
Ching-Fu Weng, Chien‐Chih Wu, Mei-Hsuan Wu, Fang‐Ju Lin
Topics & Concepts
MedicineLamaIndacaterolHazard ratioPropensity score matchingCOPDExacerbationInternal medicineProportional hazards modelConfidence intervalLung functionLungChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and MechanismsPharmacological Effects and Assays